4//SEC Filing
Weiss Lawrence Martin 4
Accession 0001077183-20-000033
CIK 0001077183other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:06 PM ET
Size
12.5 KB
Accession
0001077183-20-000033
Insider Transaction Report
Form 4
Weiss Lawrence Martin
Chief Scientific Officer
Transactions
- Award
Common Stock
2020-03-02+5,824→ 11,717 total - Award
Common Stock
2020-03-02$28.33/sh+37,514$1,062,772→ 37,514 totalExercise: $28.33From: 2021-03-02Exp: 2027-03-02→ Common Stock (37,514 underlying)
Holdings
- 25,000
Stock Option (Right to Buy)
Exercise: $13.87From: 2019-12-12Exp: 2023-12-12→ Common Stock (25,000 underlying) - 36,022
Stock Option (Right to Buy)
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (36,022 underlying)
Footnotes (3)
- [F1]On December 12, 2018, Dr. Weiss was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F2]On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001761625
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:06 PM ET
- Size
- 12.5 KB